io9

Deathstalker scorpion venom may aid anti-brain cancer gene therapy

By Cyriaque Lamar Published August 11, 2010, 7:00 pm ET

Reading time 1 minute

https://www.youtube.com/watch?v=GXAGMAV9L3Y

UWashington researchers have found that chlorotoxins in deathstalker scorpion venom may become a crucial component in gene therapies designed to combat glioma, the most prevalent brain cancer. The chlorotoxin facilitates the delivery of therapeutic genes into cancerous cells. [ACS Nano]

Explore more on these topics

Arachnids Cancer Medicine

Share this story

Sign up for our newsletters

Subscribe and interact with our community, get up to date with our customised Newsletters and much more.

Related Articles

Vapes

Vaping Comes With a Cancer Risk, Review Finds

The researchers say it's still not possible to quantify the exact risk of cancer caused by these products, however.

Health Ed Cara Mar 31

Three Mile Microsoft Constellation Nuclear

A New Study Links Living Near Nuclear Plants to Higher Cancer Death Rates

A nationwide analysis found that counties closer to nuclear power plants have higher cancer mortality rates.

Politics Bruce Gil Mar 1

Injectable Pens

The Link Between GLP-1 Drugs and Thyroid Cancer Could Be Smoke and Mirrors

A new review finds no convincing evidence that drugs like Ozempic raise people's risk of common thyroid cancers.

Health Ed Cara Feb 17

Fmtpills

Could Poop Pills Be a Secret Weapon Against Cancer?

Two new studies highlight the potential of fecal microbiota transplantation as a boon to cancer immunotherapy.

Health Ed Cara Jan 30

Colorblindtest

A Bizarre Link Between Colorblindness and Bladder Cancer Might Actually Make Total Sense

Colorblind people might have a unique disadvantage in noticing an early warning sign of certain cancers, a new study suggests.

Health Ed Cara Jan 27

Brainmri

What If Cancer Holds the Key to New Treatments for Alzheimer’s Disease?

Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's.

Health Ed Cara Jan 26

Sign up for our newsletters